The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company, provides the following update with respect to a revaluation of the Company's Southport pharmaceutical manufacturing facility of $14.58 million with an unmatched domestic manufacturing capability.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis company, after an extensive executive search, has appointed Ken Charteris as Group Chief Executive Officer, effective 11 July 2018.
The Hydroponics Company Limited (ASX:THC) (OTCMKTS:HDRPF), Australia's leading Medicinal Cannabis Company has signed a binding Letter of Intent with Endoca BV.
The Hydroponics Company Limited (ASX:THC), Australia's leading medicinal cannabis company1, provides the following update with respect to the Company's North American development plans.
The Hydroponics Company Limited (ASX:THC) is pleased to advise THC Pharma Pty Ltd, a wholly owned subsidiary of THC, has concluded a Letter of Intent with Ascent Industries Corp.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to note the attached news release by Harvest One Cannabis Inc. (CVE:HVT) confirming the appointment of Grant Froese as its new CEO.
It is obvious by the many genuine questions and observations from shareholders to Queensland Bauxite (ASX:QBL) that although six weeks was spent both by the company and ASX to make sure that the company merger/re-compliance announcement informed shareholders to the maximum, nevertheless there are still questions arising from the lengthy announcement which some shareholders feel need to be addressed.
